Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS-CoV-2 by RT-PCR Test.
作者信息
Koç Ahmet, Doğru Ömer, Eker Nurşah, Tufan Taş Burcu, Şenay Rabia Emel
机构信息
Marmara University Faculty of Medicine, Department of Pediatric Hematology and Oncology, İstanbul, Turkey
Marmara University Training and Research Hospital, Pediatric Bone Marrow Transplant Unit, İstanbul, Turkey
出版信息
Turk J Haematol. 2022 Jun 1;39(2):150-151. doi: 10.4274/tjh.galenos.2022.2022.0086. Epub 2022 Apr 26.
Abstract
摘要
相似文献
1
Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS-CoV-2 by RT-PCR Test.对一名急性髓系白血病患者进行来自经逆转录聚合酶链反应（RT-PCR）检测SARS-CoV-2呈阳性的同胞供者的造血干细胞移植。
Turk J Haematol. 2022 Jun 1;39(2):150-151. doi: 10.4274/tjh.galenos.2022.2022.0086. Epub 2022 Apr 26.
2
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.单倍体造血细胞移植治疗成人急性髓系白血病：欧洲血液和骨髓移植学会急性白血病工作组的立场声明。
Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.
3
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.未经调控的单倍体相合与同胞相合供者造血干细胞移植治疗伴有中高危细胞遗传学异常的急性髓系白血病患者在首次完全缓解后的结果：来自欧洲血液和骨髓移植学会急性白血病工作组的一项研究。
Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.
4
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.在年龄大于 50 岁的急性髓系白血病患者中，来自同胞和匹配无关供体的异基因干细胞移植的可比长期结果：代表欧洲血液和骨髓移植学会急性白血病工作组的报告。
Biol Blood Marrow Transplant. 2019 Nov;25(11):2251-2260. doi: 10.1016/j.bbmt.2019.06.031. Epub 2019 Jul 2.
5
Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.未处理的单倍体相合供者移植与同基因供者相比，对未缓解状态的难治/复发急性髓系白血病有更好的抗白血病效果。
Ann Hematol. 2020 Dec;99(12):2911-2925. doi: 10.1007/s00277-020-04283-0. Epub 2020 Oct 1.
6
Planned hematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukemia and persistent SARS-CoV-2 infection.一名17个月大的高危急性髓系白血病且持续感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的患者计划进行造血干细胞移植。
Transfusion. 2021 May;61(5):1657-1659. doi: 10.1111/trf.16361. Epub 2021 Mar 25.
7
Haploidentical unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT.亲缘半相合非亲缘异基因造血干细胞移植治疗复发/难治性急性髓系白血病：来自 EBMT 急性白血病工作组的 1578 例患者报告。
Haematologica. 2019 Mar;104(3):524-532. doi: 10.3324/haematol.2017.187450. Epub 2018 Oct 25.
8
Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.移植物来源对接受减低强度或非清髓性预处理的成年急性髓系白血病患者无关供者造血干细胞移植的影响：来自法国骨髓移植与细胞治疗协会的一项研究
Biol Blood Marrow Transplant. 2015 Jun;21(6):1059-67. doi: 10.1016/j.bbmt.2015.02.014. Epub 2015 Feb 20.
9
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over.预处理强度对 45 岁及以上急性髓系白血病患者行单倍体造血干细胞移植结局的影响。
Cancer. 2019 May 1;125(9):1499-1506. doi: 10.1002/cncr.31941. Epub 2019 Jan 8.
10
Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.来自感染了新冠病毒的供体同胞的造血干细胞移植。
Bone Marrow Transplant. 2020 Dec;55(12):2359-2360. doi: 10.1038/s41409-020-0969-3. Epub 2020 Jun 11.
引用本文的文献
1
[Allogeneic hematopoietic stem cell transplantation during the normalization stage of COVID-19 management].[新型冠状病毒肺炎管理正常化阶段的异基因造血干细胞移植]
Zhonghua Xue Ye Xue Za Zhi. 2024 Nov 14;45(11):977-981. doi: 10.3760/cma.j.cn121090-20240817-00308.
2
The impact of the donors' COVID-19 status on the outcomes of allogeneic hematopoietic stem cell transplantation: a multi-center retrospective study.供者新冠病毒病状态对异基因造血干细胞移植结局的影响：一项多中心回顾性研究
Front Microbiol. 2024 Jul 15;15:1415289. doi: 10.3389/fmicb.2024.1415289. eCollection 2024.
3
Successful Hematopoietic Stem Cell Transplantation from a Donor Sibling Infected with SARS-CoV-2 Using Molnupiravir Prophylaxis.使用莫努匹韦进行预防，成功实现从感染了SARS-CoV-2的同胞供体进行造血干细胞移植。
Turk J Haematol. 2023 May 29;40(2):135-136. doi: 10.4274/tjh.galenos.2023.2022.0526. Epub 2023 May 15.
4
COVID-19 systematic screening of asymptomatic haematopoietic stem cell donors: Less if often more.对无症状造血干细胞捐献者进行2019冠状病毒病系统筛查：少即是多。
EJHaem. 2022 Sep 15;3(4):1381-4. doi: 10.1002/jha2.556.
本文引用的文献
1
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors.来自新冠病毒阳性供体的异基因造血干细胞移植。
Lancet Haematol. 2021 Mar;8(3):e167-e169. doi: 10.1016/S2352-3026(21)00025-9. Epub 2021 Feb 1.
2
No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19.在接受来自匹配相关供体的异基因造血细胞移植且供体新冠病毒病情况未知的患者中，未发生严重急性呼吸综合征冠状病毒2（SARS-CoV-2）传播。
Transfus Apher Sci. 2020 Dec;59(6):102921. doi: 10.1016/j.transci.2020.102921. Epub 2020 Aug 24.
3
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.造血细胞移植和细胞治疗受者 COVID-19 管理指南。
Biol Blood Marrow Transplant. 2020 Nov;26(11):1983-1994. doi: 10.1016/j.bbmt.2020.07.027. Epub 2020 Jul 28.
4
Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.来自感染了新冠病毒的供体同胞的造血干细胞移植。
Bone Marrow Transplant. 2020 Dec;55(12):2359-2360. doi: 10.1038/s41409-020-0969-3. Epub 2020 Jun 11.
5
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.COVID-19 和造血细胞移植面临的挑战；EBMT 关于造血细胞移植受者、供者和接受 CAR-T 细胞治疗患者管理的建议。
Bone Marrow Transplant. 2020 Nov;55(11):2071-2076. doi: 10.1038/s41409-020-0919-0. Epub 2020 May 13.
6
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病：冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
Zotero 插件